2022
HEALTH POLICY AND PLANNING, (2022).37 8
2022
European Respiratory Journal, (2022).59 4
2022
medRxiv (2022).
2022
PloS one, (2022).17 1
Re-evaluating pathways through the spectrum of tuberculosis disease following M. tuberculosis infection.
2022
(2022).
2022
The Lancet Microbe, (2022).3 4
2022
CLINICAL INFECTIOUS DISEASES, (2022).75 2
2022
BMJ Open, (2022).12 7
2022
European respiratory review, (2022).31 164
Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversion. S1 Data.
2022
, PLOS ONE (2022).